Skip to main content

Advertisement

Log in

Axillary Reverse Mapping (ARM): A New Concept to Identify and Enhance Lymphatic Preservation

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Variations in arm lymphatic drainage put the arm lymphatics at risk for disruption during axillary lymph node surgery. Mapping the drainage of the arm with blue dye (axillary reverse mapping, ARM) decreases the likelihood of disruption of lymphatics and subsequent lymphedema.

Methods

This institutional review board (IRB)-approved study from May to October 2006 involved patients undergoing SLNB and/or ALND. Technetium sulfur colloid (4 mL) was injected in the subareolar plexus and 2–5 mL of blue dye intradermally was injected in the ipsilateral upper extremity (ARM). Data were collected on variations in lymphatic drainage that impacted SLNB or ALND, successful identification and protection of the arm lymphatics, any crossover between a hot breast node and a blue arm node, and occurrence of lymphedema.

Results

Of the 40 patients undergoing surgery for breast cancer, 18 required an ALND, with a median age of 49.7 years old. Fourteen patients had a SLNB + ALND, and four patients had ALND alone. In 100% of patients, all breast SLNs were hot but not blue, and the false negative rate was 0. In 11 of 18 ALNDs (61%) blue lymphatics or blue nodes were identified in the axilla. In the initial seven cases with positive lymph nodes in the axilla, the blue node draining from the arm was biopsied and all were negative.

Conclusions

ARM identified significant lymphatic variations draining the upper extremities and facilitated preservation in all but one case. ARM added to present-day ALND and SLNB further defines the axilla and may be useful to prevent lymphedema.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

FIG. 1.
FIG. 2.

Similar content being viewed by others

References

  1. Ivens D, et al. Assessment of morbidity from complete axillary dissection. Br J Cancer 1997; 66:136

    Google Scholar 

  2. Temple LK, Baron R, Cody HS 3rd, et al. Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol 2002; 9(7):654–62

    PubMed  Google Scholar 

  3. Somers RG, et al. The use of closed suction drainage after lumpectomy and axillary node dissection for breast cancer; a prospective randomized trial. Ann Surg 1992; 215:146

    Article  PubMed  CAS  Google Scholar 

  4. Schrenk P, Rieger R, Shamiyeh A, et al. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 2000; 88:608–14

    Article  PubMed  CAS  Google Scholar 

  5. Haid A, Koberle-Wuhrer R, Knauer M, Burtscher J, Fritzsche H, Peschina W, Jasarevic Z, Ammann M, Hergan K, Sturn H, Zimmermann G. Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 2002; 73(1):31–6

    Article  PubMed  Google Scholar 

  6. Swenson KK, Nissen MJ, Ceronsky C, Swenson L, Lee MW, Tuttle TM. Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol 2002; 9(8):745–53

    Article  PubMed  Google Scholar 

  7. Blanchard DK, Donohue JH, Reynolds C, et al. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 2003; 138:482–8

    Article  PubMed  Google Scholar 

  8. Schijven MP, Vingerhoets AJ, Rutten HJ, et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 2003; 29:341–50

    Article  PubMed  CAS  Google Scholar 

  9. Ronka R, von Smitten K, Tasmuth, et al. One-year morbidity after sentinel node biopsy and breast surgery. Breast 2005; 14:28–36

  10. Leidenius M, Leivonen M, Vironen J, von Smitten K. The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance. J Surg Oncol 2005; 92(1):23–31

    Article  PubMed  CAS  Google Scholar 

  11. Mansel R, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC Trial: JNCI 2006; 98(9):599–609

    PubMed  Google Scholar 

  12. Passik SD, McDonald MV. Psychosocial aspects of upper extremity lymphedema in women treated for breast carcinoma. Cancer 1998; 83:2817–20

    Article  PubMed  CAS  Google Scholar 

  13. Tobin MB, Lacey HJ, Meyer L, Mortimer PS. The psychosocial morbidity of breast cancer-related arm swelling. Psychological morbidity of lymphoedema. Cancer 1993; 72:3248–52

    Article  PubMed  CAS  Google Scholar 

  14. Sener SF, Winchester DJ, Martz CH, et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer 2001; 92(4):748–52

    Article  PubMed  CAS  Google Scholar 

  15. Wilke LG, McCall LM, Posther KE, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 2006; 13(4):491–500

    Article  PubMed  Google Scholar 

  16. Layeeque R, Kepple J, Henry-Tillman RS, Adkins L, Kass R, Colvert M, Gibson R, Mancino A, Korourian S, Klimberg VS. Intraoperative subareolar radioisotope injection for immediate sentinel lymph node biopsy. Ann Surg 2004; 239(6):841–5; discussion 845–8

    Article  PubMed  Google Scholar 

  17. Descriptive Statistics. www.physics.csbsju.edu/stats/cstats NROW_form. Html

  18. Fisher B, Slack NH. Number of lymph nodes examined and the prognosis of breast carcinoma. Surg Gynecol Obstet 1970; 131:79

    PubMed  CAS  Google Scholar 

  19. Fisher B, Fisher ER, Redmond C. Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of Lphenylalanine mustard (L-PAM) in the management of primary breast cancer. J Clin Oncol 1986; 4:929

    PubMed  CAS  Google Scholar 

  20. Giuliano A, Schwartz G. Summary of the proceedings of the Philadelphia Consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast. Semin Breast Dis 2002; 5:110

    Google Scholar 

  21. Noguchi M, Taniya T, Ohta N, et al. Lymph node metastases versus DNA ploidy as prognostic factors for invasive ductal carcinoma of the breast. Breast Cancer Res Treat 1991; 19(1):23–31

    Article  PubMed  CAS  Google Scholar 

  22. http://www.cancer.org/downloads/STT/CAFF2006PWsecured.pdf

  23. http://www.seer.cancer.gov/faststats/sites.php?site=Breast%20Cancer&stat=Incide nce

  24. Bland K, Copeland E. The Breast: Comprehensive Management of Benign and Malignant Disorders, 3rd ed. St. Louis: Saunders, 2004

    Google Scholar 

  25. Kissin MW, della Rovere QG, Easton D, Westbury G. Risk of lymphedema following the treatment of breast cancer. Br J Surg 1986; 73:580–4

    Article  PubMed  CAS  Google Scholar 

  26. Delouche G, Bachelot F, Premont M, Kurtz JM. Conservation treatment of early breast cancer: long term results and complications. Int J Radiat Oncol Biol Phys 1987; 13:29–34

    PubMed  CAS  Google Scholar 

  27. Larson D, Weinstein M, Goldberg I, et al. Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys 1986; 12:1575–82

    PubMed  CAS  Google Scholar 

  28. Petrek JA, Senie RT, Peters M, et al. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 2001; 92:1368–77

    Article  PubMed  CAS  Google Scholar 

  29. Velanovich V, Szymanski W. Quality of life of breast cancer patients with lymphedema. Am J Surg 1999; 177:184–7

    Article  PubMed  CAS  Google Scholar 

  30. Kwan W, Jackson J, Weir LM, et al. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol 2002; 20:4242–8

    Article  PubMed  Google Scholar 

  31. Silberman AW, McVay C, Cohen JS, et al. Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique: implications for patients with breast cancer. Ann Surg 2004; 240:1–6

    Article  PubMed  Google Scholar 

  32. Sener SF, Winchester DJ, Martz CH, et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer 2001; 92:748–52

    Article  PubMed  CAS  Google Scholar 

  33. Britton TM, Buczacki SJ, Turner CL, et al. Venous changes and lymphedema 4 years after axillary surgery for breast cancer. Br J Surg 2007; Epub Mar 2007

  34. Soran A, D’Angelo G, Begovic M, et al. Breast cancer-related lymphedema—what are the significant predictors and how they affect the severity of lymphedema. Breast J 2006; 12(6):536–43

    Article  PubMed  Google Scholar 

  35. McMasters KM, Giuliano AE, Ross MI, Reintgen DS, Hunt KK, Byrd DR, Klimberg VS, Whitworth PW, Tafra LC, Edwards MJ. Sentinel Lymph Node Biopsy for Breast Cancer—Not Yet the Standard of Care. N Engl J Med. 1998; 339:990–995

    Article  PubMed  CAS  Google Scholar 

  36. Leidenius M, Leppanen E, Krogerus L, et al. Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer. Am J Surg 2003; 185:127–30

    Article  PubMed  Google Scholar 

  37. Burak WE, Hollenbeck ST, Zervos EE, et al. Sentinel lymph node biopsy results in less post operative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 2002; 183:23–7

    Article  PubMed  Google Scholar 

  38. Rubio IT, Korourian S, Colvert M, Westbrook KC, Klimberg VS. Sentinel Lymph Node Biopsy for the Staging of Breast Cancer. Am J Surg 1998; 176(6):532–7

    Article  PubMed  CAS  Google Scholar 

  39. Sakorafas GH, Peros G, Cataliotti L, et al. Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol 2006; 15(3):153–65

    Article  PubMed  Google Scholar 

  40. Uren RF, Howman-Giles R, Thompson JF. Patterns of lymphatic drainage from the skin in patients with melanoma. J Nucl Med 2003; 44(4):570–82

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V Suzanne Klimberg MD.

Additional information

Supported by the Susan G. Komen Breast Cancer Clinical Fellowship and the Arkansas Breast Cancer Act

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thompson, M., Korourian, S., Henry-Tillman, R. et al. Axillary Reverse Mapping (ARM): A New Concept to Identify and Enhance Lymphatic Preservation. Ann Surg Oncol 14, 1890–1895 (2007). https://doi.org/10.1245/s10434-007-9412-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-007-9412-x

Keywords

Navigation